UMB Dataset
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
UID: 189
- Description
- This study investigates multiple vaccine strategies to enhance immunogenicity and protection against SARS-CoV-2 in aged mice. The study aims to determine the effect of a booster dose, with an emphasis on older age. Female three and eleven-month-old BALB/c mice were studied over the course of 38 weeks. Mice received BNT162b2 SARS-CoV-2 spike mRNA vaccine series, primary vaccination series, and mock Phosphate-buffered saline (PBS) injections. Single mouse experiments aimed to include 20 mice per group. Sample size and age criteria were chosen empirically based on the results of previous studies. Mice were randomly assigned to different treatment groups.
- Local Experts
Access
- Restrictions
-
Unrestricted access
- Instructions
- All data supporting the findings of this study are available within the supplementary information files (Supplementary Data 1). The data corresponds to the figures that are in the article.
Interventional
Longitudinal
- Grant Support
-
HHSN272201400052C/United States. National Institute of Allergy and Infectious Diseases75N93019C00044/United States. National Institute of Allergy and Infectious DiseasesHHSN272201800047C/United States. National Institute of Allergy and Infectious Diseases1R21AI137932-01A1/National Institutes of Health (U.S.)ASPR-20-01495/Biomedical Advanced Research and Development Authority (U.S.)